Loading…
Natera, Inc. is projected to rise to $229.01 by 2027, a +13% move from its current price of $203.11. NTRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $197.74 | $203.15 | $208.70 | +0.02% |
| May 30 | $195.58 | $203.18 | $211.08 | +0.04% |
| May 31 | $193.95 | $203.22 | $212.94 | +0.05% |
| Jun 1 | $192.59 | $203.26 | $214.52 | +0.07% |
| Jun 2 | $191.40 | $203.30 | $215.93 | +0.09% |
| Jun 3 | $190.34 | $203.33 | $217.21 | +0.11% |
| Jun 4 | $189.37 | $203.37 | $218.41 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $189.37 | $203.37 | $218.41 | +0.13% |
| Week 2 | $184.09 | $203.63 | $225.24 | +0.26% |
| Week 3 | $180.20 | $203.89 | $230.70 | +0.39% |
| Week 4 | $177.01 | $204.15 | $235.46 | +0.51% |
| Week 5 | $174.28 | $204.42 | $239.76 | +0.64% |
| Week 6 | $171.87 | $204.68 | $243.75 | +0.77% |
| Week 7 | $169.70 | $204.94 | $247.51 | +0.90% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Natera, Inc. is a diagnostics company that develops and commercializes molecular testing services worldwide. Its portfolio includes Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.
The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions.
In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company has a partnership agreement with BGI Genomics Co., Ltd.
to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company was founded in 2003 and is headquartered in Austin, Texas. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model.
Natera, Inc. (NTRA) is currently trading at $203.19, with a market cap of $29B, and is ranked 5525.
The near-term technical picture is bullish, with RSI14 at 50, and moving averages at SMA50 $201.33 and SMA200 $201.55; support is at $186.36 and resistance at $219.82.
The 30-day price range runs from $167.85 to $244.35.
Forecasts show a rising path, with the 2026 average price of $202.52, 2027 $226.26, 2028 $285.60, 2029 $335.34, 2030 $386.27, 2031 $415.54, 2032 $434.87, 2033 $452.28, 2034 $464.84, 2035 $574.32, 2040 $809.24, and 2050 $1,748.87 as the average prices. The corresponding ROI figures progress from 0 in 2026 to 11.7 in 2027, 41 in 2028, 65.6 in 2029, 90.7 in 2030, 105.2 in 2031, 114.7 in 2032, 123.3 in 2033, 129.5 in 2034, 183.6 in 2035, 299.6 in 2040, and 763.5 in 2050, with sentiment turning bullish in the later years.
A major floor 16.5% below — a decisive break under it would weaken the trend.
The nearest floor, 8.2% below — buyers have tended to step in here.
The nearest ceiling, 8.2% above — a clean break opens room to run.
A major ceiling 19.6% above — clearing it would confirm fresh momentum.
Key NTRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NTRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $203.16 | Sell | $201.73 | Buy |
| MA 10 | $198.30 | Buy | $201.01 | Buy |
| MA 20 | $202.10 | Buy | $201.41 | Buy |
| MA 50 | $201.69 | Buy | $203.26 | Sell |
| MA 100 | $210.60 | Sell | $204.81 | Sell |
| MA 200 | $202.10 | Buy | $197.97 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.98 | Neutral |
| Stoch RSI (14) | 53.38 | Neutral |
| CCI (20) | 10.73 | Neutral |
| Williams %R (14) | -49.94 | Info |
| MACD (12,26,9) | 0.36 | Buy |
| ROC (12) | 4.57 | Buy |
| Bollinger %B (20,2) | 0.53 | Neutral |
| Stochastic %K (14) | 50.06 | Neutral |
| TRIX (15) | -0.07 | Sell |
| Awesome (5,34) | 0.32 | Buy |
| Ultimate (7,14,28) | 67.66 | Neutral |
| Momentum (10) | -1.10 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 205.05 | Sell |
| ADX (14) | 6.90 | Neutral |
| ATR (14) | 5.34 | Info |
The 30-day technical picture is bullish in the near term. RSI14 sits at 50, with a SMA50 of $201.33 and a SMA200 of $201.55, indicating that price action is above the short-term trend line but not yet overbought.
Support is reported at $186.36 and resistance at $219.82, providing a defined trading corridor. The 30-day price range spans from $167.85 up to $244.35, framing a window for near-term movement.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $182.65 | $203.11 | $258.65 | 0% | Neutral | |
| $181.85 | $229.01 | $305.39 | +13% | Neutral | |
| $215.68 | $278.98 | $385.39 | +37% | Bullish | |
| $247.44 | $327.30 | $464.95 | +61% | Bullish | |
| $275.24 | $371.38 | $540.18 | +83% | Bullish | |
| $290.51 | $399.15 | $592.74 | +97% | Bullish | |
| $305.09 | $426.33 | $645.00 | +110% | Bullish | |
| $312.99 | $444.38 | $683.76 | +119% | Bullish | |
| $319.27 | $460.19 | $719.20 | +127% | Bullish | |
| $379.02 | $554.28 | $878.87 | +173% | Bullish | |
| $501.49 | $783.15 | $1,319.55 | +286% | Bullish | |
| $945.43 | $1,653.15 | $3,044.09 | +714% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $182.65 | $203.11 | $237.90 | +0.00% |
| June 2026 | $171.11 | $200.90 | $241.43 | -1.09% |
| July 2026 | $174.46 | $206.53 | $251.52 | +2.80% |
| August 2026 | $175.33 | $208.91 | $257.04 | +1.15% |
| September 2026 | $169.40 | $202.94 | $251.77 | -2.86% |
| October 2026 | $167.16 | $201.24 | $251.55 | -0.84% |
| November 2026 | $170.07 | $205.64 | $258.74 | +2.19% |
| December 2026 | $168.25 | $204.29 | $258.65 | -0.66% |
Click any year to see its month-by-month NTRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, NTRA could reach as high as $258.65, with a base case around $203.11 and support toward $182.65 — roughly 0% from $203.11. Price action looks broadly range-bound.
Expect NTRA to range from $181.85 to $305.39 through 2027. The $229.01 average target implies a +13% move from current prices. That is up +13% on the projected 2026 average. A consolidation phase looks the most probable path here.
The NTRA price prediction for 2028 points to an average of $278.98 (low $215.68, high $385.39) — a potential gain of +37% on today's $203.11. Momentum favours further upside here.
In 2029, NTRA is projected to trade between $247.44 and $464.95, averaging $327.30 — a potential gain of +61% from today's $203.11. That is up +17% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Natera, Inc.'s 2030 outlook centres on $371.38, within a $275.24 to $540.18 range. That is up +13% on the projected 2029 average. That marks a +83% change versus current levels. Momentum favours further upside here.
By 2031, NTRA could reach as high as $592.74, with a base case around $399.15 and support toward $290.51 — roughly +97% from $203.11. Buyers look set to stay in control over this stretch.
Expect NTRA to range from $305.09 to $645.00 through 2032. The $426.33 average target implies a +110% move from current prices. That is up +7% on the projected 2031 average. Momentum favours further upside here.
The NTRA price prediction for 2033 points to an average of $444.38 (low $312.99, high $683.76) — a potential gain of +119% on today's $203.11. Buyers look set to stay in control over this stretch.
In 2034, NTRA is projected to trade between $319.27 and $719.20, averaging $460.19 — a potential gain of +127% from today's $203.11. That is up +4% on the projected 2033 average. Momentum favours further upside here.
Natera, Inc.'s 2035 outlook centres on $554.28, within a $379.02 to $878.87 range. That is up +20% on the projected 2034 average. That marks a +173% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, NTRA could reach as high as $1,319.55, with a base case around $783.15 and support toward $501.49 — roughly +286% from $203.11. Momentum favours further upside here.
Expect NTRA to range from $945.43 to $3,044.09 through 2050. The $1,653.15 average target implies a +714% move from current prices. That is up +111% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NTRA today (≈ 4.923441 NTRA) could be worth
$8,139.21
+$7,139.21 (+714%) by 2050 · US Dollar
Based on the average projected NTRA price of $1,653.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NTRAwould be worth at today's price.
$1,000 invested in NTRA on May 27, 2025 (≈ 6.362942 NTRA) would be worth
$1,292.38
+$292.38 (+29.2%) today · 1.29× · US Dollar
Based on a NTRA entry price of $157.16 vs. today's $203.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $204.92 | $991.17 | -0.9% |
| 1 month ago | $204.39 | $993.74 | -0.6% |
| 3 months ago | $216.1 | $939.89 | -6.0% |
| 6 months ago | $238.81 | $850.51 | -14.9% |
| 1 year ago | $157.16 | $1,292.38 | +29.2% |
| All time (5.0y) ago | $92 | $2,207.72 | +120.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NTRA forecast.
Our base-case forecast reaches $410.00 around 2032.
Implied market cap at $410.00: $58.72B
The multi-year forecast portrays a persistent upward trajectory, with average prices rising from $202.52 in 2026 to $1,748.87 in 2050. The forecast highlights notable milestones: 2030 average of $386.27 with ROI 90.7 and bullish sentiment; 2040 average of $809.24 with ROI 299.6 and bullish sentiment; and 2050 average of $1,748.87 with ROI 763.5 and bullish sentiment.
Beyond 2030, the forecast shows continuing gains with 2031 ($415.54), 2032 ($434.87), 2033 ($452.28), 2034 ($464.84), and 2035 ($574.32) all marked as bullish, culminating in substantial long-term upside by 2040 and 2050. These figures illustrate a strong growth path, tempered by the inherent uncertainty that accompanies any forward-looking projection.
Tap a question to reveal the answer.
The average forecast price for 2030 is $386.27 with ROI 90.7 and a BULLISH sentiment.
The 30-day range is from $167.85 to $244.35.
Yes. The 2050 max forecast is $3,544.57, with a 2050 average of $1,748.87 and ROI 763.5.
The forecast shows a bullish trajectory in the later years, with the average rising to $386.27 by 2030 (ROI 90.7) and to $1,748.87 by 2050 (ROI 763.5), though these are estimates and not guarantees.
The 2026 forecast shows an average price of $202.52, with a min of $182.65 and a max of $258.06, and ROI of 0, with neutral sentiment.
Natera, Inc. Community Discussion
0Share your Natera, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.